**
Recent research has revealed alarming levels of per- and polyfluoroalkyl substances (PFAS), commonly known as ‘forever chemicals’, in umbilical cord blood, potentially indicating greater fetal exposure than previously understood. A study conducted by Mount Sinai researchers, analysing 120 samples, uncovered 42 distinct PFAS compounds, highlighting a significant public health concern regarding the implications for unborn children.
Uncovering the Extent of PFAS Exposure
Traditionally, testing on umbilical cord blood has focused on a limited array of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, this new investigation employed a more comprehensive “non-targeted analysis” technique, which allowed researchers to identify a broader spectrum of PFAS substances. This method revealed that the total PFAS levels in umbilical blood were considerably higher than past assessments indicated.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, noted, “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.” The findings suggest that babies are being exposed to a complex cocktail of PFAS, raising questions about the potential health risks associated with such exposure.
The Health Risks Associated with PFAS
PFAS are a group of approximately 15,000 synthetic chemicals renowned for their water-, stain-, and grease-resistant properties. However, they have been implicated in a range of serious health issues, including cancer, developmental disorders, reduced immune function, and cardiovascular disease. The term ‘forever chemicals’ stems from their persistence in the environment and the human body, resisting natural degradation processes.
Research indicates that elevated PFAS levels in pregnant individuals correlate with adverse outcomes such as increased infant mortality, low birth weight, and developmental challenges, including obesity later in life. Furthermore, studies have linked prenatal exposure to these chemicals with long-term health issues, including neurological and cardiovascular problems.
A review encompassing 40 studies found PFAS in every one of the 30,000 umbilical cord blood samples examined, underscoring the widespread nature of this exposure. The presence of these compounds in fetal blood signifies that unborn children are entering the world with a concerning chemical burden.
Regulatory Oversight and Testing Limitations
Despite the growing body of evidence regarding the dangers posed by PFAS, regulatory frameworks have struggled to keep pace with the evolving landscape of chemical exposure. The US Environmental Protection Agency (EPA) has historically tested for only a limited number of PFAS compounds—around 30-40—while independent researchers have identified thousands in various environmental samples.
The Mount Sinai study highlights the inadequacies of existing testing methodologies. Although the EPA recently certified a blood test capable of detecting 53 PFAS compounds, Liu pointed out that the study’s broader analysis identified 31 compounds not included in the EPA’s recent tests. This disparity raises concerns about the regulatory capacity to adequately monitor and manage the risks associated with these omnipresent chemicals.
Implications for Future Research
While the Mount Sinai study did not directly assess the health effects of the identified PFAS levels, the correlation between higher blood concentrations and increased health risks remains a significant concern. The blood samples analysed were part of the federal government’s Home Study, which tracks PFAS exposure and associated health outcomes over time. Researchers at Mount Sinai plan to further investigate the potential health implications of their findings.
David Andrews, acting chief science officer with the Environmental Working Group, remarked, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.” The urgency of this issue cannot be overstated, as it illustrates the potential long-term consequences of inadequate regulatory frameworks in protecting vulnerable populations.
Why it Matters
The revelation that fetuses may be exposed to a wider array of PFAS than previously recognised underscores a critical public health challenge. As these chemicals are linked to severe health risks, the findings necessitate an urgent reevaluation of regulatory policies and testing procedures. Protecting unborn children from harmful chemical exposure should be a priority, emphasising the need for stringent health-protective regulations to ensure a healthier future for the next generation. In light of this research, it is imperative that both the public and policymakers act to mitigate the risks posed by these persistent environmental contaminants.
